Feinstein Institutes Researchers Demonstrate Successful Study of Lupus Kidney Disease
Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of […]
